BURLINGTON, Mass., Sept. 3, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer, announced today that Dr. Harlan F. Weisman, Coronado's Chairman and CEO, will present at the following upcoming investor conferences:
- Baird's 2013 Health Care Conference on Tuesday, September 10, 2013 at 2:55 PM ET. The conference will be held at The New York Palace on September 10-11, 2013.
- Stifel Nicolaus 2013 Healthcare Conference on Thursday, September 12, 2013 at 11:30 AM ET. The conference will be held September 11-12, 2013 at the Four Seasons in Boston, MA. A webcast of the presentation will be available at www.coronadobiosciences.com on the Events & Webcasts page.
CONTACT: Lucy Lu, MD, Executive Vice President & Chief Financial Officer Coronado Biosciences, Inc. 781-652-4525; email@example.com Marcy Nanus, Vice President The Trout Group, LLC. 646-378-2927; firstname.lastname@example.org Susan Forman Dian Griesel Inc. 212-825-3210; email@example.com